View in EDS HTML Full Text PDF Full Text

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab.

Saved in:
Bibliographic Details
Title: Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab.
Authors: Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Madison RW; Foundation Medicine, Inc., Boston, MA, USA., Tambaoan CFB; Foundation Medicine, Inc., Boston, MA, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sweeney CJ; University of Adelaide, Adelaide, Australia., Kurzrock R; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, TN, USA., Spigel DR; Sarah Cannon Research Institute, Nashville, TN, USA., Tukachinsky H; Foundation Medicine, Inc., Boston, MA, USA., Hughes J; Foundation Medicine, Inc., Boston, MA, USA., Malato J; Genentech, Inc., South San Francisco, CA, USA., Yoo B; Genentech, Inc., South San Francisco, CA, USA., Szado T; Genentech, Inc., South San Francisco, CA, USA., Schwab C; Genentech, Inc., South San Francisco, CA, USA., Pasquina LW; Foundation Medicine, Inc., Boston, MA, USA., Gasco A; Foundation Medicine, Inc., Boston, MA, USA., Schulze K; Genentech, Inc., South San Francisco, CA, USA., Friedman CF; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Source: Molecular oncology [Mol Oncol] 2025 Nov; Vol. 19 (11), pp. 3060-3078. Date of Electronic Publication: 2025 May 28.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40434907
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Swanton+C%22">Swanton C</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.<br /><searchLink fieldCode="AU" term="%22Madison+RW%22">Madison RW</searchLink>; Foundation Medicine, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tambaoan+CFB%22">Tambaoan CFB</searchLink>; Foundation Medicine, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Meric-Bernstam+F%22">Meric-Bernstam F</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sweeney+CJ%22">Sweeney CJ</searchLink>; University of Adelaide, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Kurzrock+R%22">Kurzrock R</searchLink>; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink>; Sarah Cannon Research Institute, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Spigel+DR%22">Spigel DR</searchLink>; Sarah Cannon Research Institute, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Tukachinsky+H%22">Tukachinsky H</searchLink>; Foundation Medicine, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+J%22">Hughes J</searchLink>; Foundation Medicine, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Malato+J%22">Malato J</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yoo+B%22">Yoo B</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Szado+T%22">Szado T</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schwab+C%22">Schwab C</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pasquina+LW%22">Pasquina LW</searchLink>; Foundation Medicine, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gasco+A%22">Gasco A</searchLink>; Foundation Medicine, Inc., Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schulze+K%22">Schulze K</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Friedman+CF%22">Friedman CF</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2025 Nov; Vol. 19 (11), pp. 3060-3078. <i>Date of Electronic Publication: </i>2025 May 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40434907
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.70054
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3060
    Titles:
      – TitleFull: Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Swanton C
      – PersonEntity:
          Name:
            NameFull: Madison RW
      – PersonEntity:
          Name:
            NameFull: Tambaoan CFB
      – PersonEntity:
          Name:
            NameFull: Meric-Bernstam F
      – PersonEntity:
          Name:
            NameFull: Sweeney CJ
      – PersonEntity:
          Name:
            NameFull: Kurzrock R
      – PersonEntity:
          Name:
            NameFull: Burris HA 3rd
      – PersonEntity:
          Name:
            NameFull: Spigel DR
      – PersonEntity:
          Name:
            NameFull: Tukachinsky H
      – PersonEntity:
          Name:
            NameFull: Hughes J
      – PersonEntity:
          Name:
            NameFull: Malato J
      – PersonEntity:
          Name:
            NameFull: Yoo B
      – PersonEntity:
          Name:
            NameFull: Szado T
      – PersonEntity:
          Name:
            NameFull: Schwab C
      – PersonEntity:
          Name:
            NameFull: Pasquina LW
      – PersonEntity:
          Name:
            NameFull: Gasco A
      – PersonEntity:
          Name:
            NameFull: Schulze K
      – PersonEntity:
          Name:
            NameFull: Friedman CF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1